Antimicrobial Agents Practice Questions

Q: Absorption of which of the following antimalarial drugs increases with food intake?

Lumefantrine. **Explanation:** The correct answer is **Lumefantrine (Option B)**. **Why Lumefantrine is correct:** Lumefantrine is a highly lipophilic antimalarial drug. Its oral bioavailability is significantly enhanced (up to 16-fold) when administered with a **fatty meal**. This is clinically critical because Lumefantrine is almost always used in fixed-dose combinations with Artemether (ACT - Artemisinin-based Combination Therapy). Since Lumefantrine has a long half-life, its adequate absorption is essential to provide the "post-treatment cover" that prevents the recrudescence of *P. falciparum* malaria. **Why the other options are incorrect:** * **Mefloquine (Option A):** While food may slightly increase its absorption, it is not as clinically significant or characteristic as it is for Lumefantrine. Mefloquine is generally well-absorbed regardless of food intake. * **Chloroquine (Option C):** Chloroquine is rapidly and almost completely absorbed from the gastrointestinal tract. Its absorption is independent of food intake. * **Amodiaquine (Option D):** Similar to Chloroquine, Amodiaquine is well-absorbed orally, and its bioavailability is not significantly altered by food. **High-Yield Clinical Pearls for NEET-PG:** * **ACT Gold Standard:** Artemether + Lumefantrine is the most widely used ACT worldwide for uncomplicated *P. falciparum*. * **The "Fatty Meal" Rule:** Patients are specifically advised to take the dose with milk or fat-containing food to ensure therapeutic levels. * **Other drugs with increased absorption with food (Mnemonic: "Griseofulvin Loves Fat"):** Griseofulvin, Albendazole, Halofantrine, and Atovaquone also show significantly increased absorption with fatty meals. * **Lumefantrine Side Effect:** It can cause QT interval prolongation (though less severe than its predecessor, Halofantrine).

Q: Which of the following statements regarding penicillin is true?

It is excreted mainly through the kidney.. **Explanation:** **Correct Option (B): It is excreted mainly through the kidney.** Penicillin G (Benzylpenicillin) is primarily eliminated by the kidneys (approx. 90% via **active tubular secretion** and 10% via glomerular filtration). Tubular secretion is mediated by the organic anion transporter (OAT). Because of this rapid clearance, penicillin has a short half-life (approx. 30 minutes). * **Clinical Correlation:** Probenecid can be co-administered to inhibit this tubular secretion, thereby increasing the plasma concentration and duration of action of penicillin. **Incorrect Options:** * **A. It is acid-resistant:** Natural Penicillin G is **acid-labile**, meaning it is destroyed by gastric acid and cannot be given orally. Only specific derivatives like Penicillin V (Phenoxymethylpenicillin) or Ampicillin are acid-stable. * **C. It is more concentrated in prostatic fluid:** Penicillins are lipid-insoluble and do not easily cross biological membranes. They achieve poor penetration into the prostate, eye, and CNS (unless the meninges are inflamed). * **D. It is a broad-spectrum antibiotic:** Penicillin G is a **narrow-spectrum** antibiotic, primarily effective against Gram-positive cocci (Streptococci), Gram-positive bacilli, and some Gram-negative cocci (Neisseria). **NEET-PG High-Yield Pearls:** 1. **Dose Adjustment:** Since it is renally excreted, dose reduction is mandatory in patients with renal failure to prevent neurotoxicity (seizures). 2. **Repository Forms:** Procaine and Benzathine penicillin are given IM to create a "depot" that bypasses the rapid renal clearance, providing sustained levels for days to weeks. 3. **Drug of Choice:** Penicillin G remains the drug of choice for **Syphilis** (*Treponema pallidum*).

Q: Which of the following drugs is used for prophylaxis of H1N1 influenza virus infections?

Oseltamivir. **Explanation:** **Oseltamivir** is the correct answer because it is a **Neuraminidase Inhibitor** effective against both Influenza A (including H1N1) and Influenza B. Neuraminidase is an enzyme essential for the release of newly formed viral particles from infected host cells. By inhibiting this enzyme, Oseltamivir prevents the spread of the virus within the respiratory tract. It is FDA-approved for both the **treatment** (within 48 hours of symptom onset) and **chemoprophylaxis** of influenza. **Analysis of Incorrect Options:** * **Abacavir:** A Nucleoside Reverse Transcriptase Inhibitor (NRTI) used exclusively in the treatment of **HIV/AIDS**. It is notably associated with HLA-B*5701 hypersensitivity reactions. * **Tenofovir:** Another NRTI used for **HIV** and **Chronic Hepatitis B** infections. It has no activity against the influenza virus. * **Acyclovir:** A guanosine analogue that inhibits viral DNA polymerase. It is the drug of choice for **Herpes Simplex Virus (HSV)** and **Varicella-Zoster Virus (VZV)**, but it is ineffective against RNA viruses like Influenza. **High-Yield NEET-PG Pearls:** * **Route of Administration:** Oseltamivir is administered **orally**, whereas **Zanamivir** is administered via inhalation (contraindicated in asthma/COPD due to bronchospasm). * **Baloxavir Marboxil:** A newer single-dose drug for influenza that inhibits **cap-dependent endonuclease**. * **Amantadine/Rimantadine:** Older drugs that inhibit the **M2 ion channel**; they are no longer recommended for H1N1 due to widespread resistance. * **Prophylaxis Dose:** For Oseltamivir, the prophylactic dose is typically 75 mg once daily, while the therapeutic dose is 75 mg twice daily.

Q: Induction of treatment in serious fungal infections is mostly done by:

IV amphotericin B. **Explanation:** **Amphotericin B** remains the "gold standard" for the induction phase of serious, life-threatening systemic fungal infections (e.g., cryptococcal meningitis, mucormycosis, and severe candidiasis) [2]. Its mechanism involves binding to **ergosterol** in the fungal cell membrane, creating pores that lead to cell death [3]. It is preferred for induction because it is **fungicidal**, has the broadest spectrum of activity of all clinically used antifungals, and develops resistance very rarely [1]. **Analysis of Incorrect Options:** * **Ketoconazole:** This is an older oral azole with significant side effects (hepatotoxicity and inhibition of steroid synthesis). It is rarely used systemically today and is never the first choice for serious induction therapy. * **5-Flucytosine:** While potent, it is never used as monotherapy due to the rapid development of resistance. It is typically used as an *adjunct* to Amphotericin B (e.g., in cryptococcal meningitis) [2]. * **Fluconazole:** Although excellent for maintenance therapy and prophylaxis due to high bioavailability, it is primarily **fungistatic**. In serious, acute infections, a fungicidal agent like Amphotericin B is required to rapidly reduce the fungal burden. **High-Yield Clinical Pearls for NEET-PG:** * **Dose-limiting toxicity:** Nephrotoxicity (causes azotemia and tubular acidosis) [3]. * **Liposomal Amphotericin B:** Preferred over the conventional deoxycholate form as it reduces nephrotoxicity and infusion-related reactions [3]. * **Infusion reactions:** Often causes "shake and bake" symptoms (fever, chills, rigors); pre-medication with NSAIDs or hydrocortisone is common [3]. * **Electrolyte imbalances:** Frequently causes **Hypokalemia** and **Hypomagnesemia**.

Q: Which fluoroquinolone is highly active against Mycobacterium leprae and is being used in alternative multidrug therapy regimens?

Ofloxacin. **Explanation:** **Ofloxacin** is the correct answer because it exhibits potent bactericidal activity against *Mycobacterium leprae*. In the context of Leprosy, it is the most widely studied and utilized fluoroquinolone for alternative Multidrug Therapy (MDT) regimens, particularly for patients who cannot tolerate standard drugs like Rifampicin or Clofazimine, or in cases of drug-resistant leprosy. * **Why Ofloxacin?** It acts by inhibiting the enzyme **DNA gyrase**, preventing bacterial DNA replication. Clinical trials have shown that a single dose of 400 mg of Ofloxacin can kill over 99% of *M. leprae* within a few days. It is a key component of the **ROM regimen** (Rifampicin + Ofloxacin + Minocycline) used for Single Lesion Paucibacillary (SLPB) leprosy. **Analysis of Incorrect Options:** * **Norfloxacin:** This is a first-generation fluoroquinolone with poor systemic absorption and low tissue penetration. It is primarily used for urinary tract infections and is ineffective against Mycobacteria. * **Ciprofloxacin:** While it does have some activity against *M. leprae*, it is less potent than Ofloxacin in clinical leprosy settings and is not typically included in standardized WHO alternative regimens. * **Lomefloxacin:** This is a second-generation quinolone with significant phototoxicity. It is not used in the treatment of leprosy. **High-Yield Clinical Pearls for NEET-PG:** * **ROM Regimen:** Rifampicin (600 mg) + Ofloxacin (400 mg) + Minocycline (100 mg) as a single dose for SLPB. * **Moxifloxacin:** Among newer fluoroquinolones, Moxifloxacin is even more bactericidal than Ofloxacin against *M. leprae*, but Ofloxacin remains the classic "textbook" answer for established alternative MDT. * **Side Effects:** Watch for tendon rupture and QTc prolongation when using fluoroquinolones.

Q: All of the following drugs are used for treating Mycobacterial Infections except?

Rifaximin. ### **Explanation** The question tests your ability to differentiate between members of the **Rifamycin** class based on their pharmacokinetic properties and clinical indications. **1. Why Rifaximin is the Correct Answer:** While Rifaximin is structurally related to Rifampicin, it is a **non-absorbable** antibiotic (<0.4% oral bioavailability). Because it remains confined to the gastrointestinal tract, it cannot reach systemic concentrations necessary to treat *Mycobacterium tuberculosis* or other systemic mycobacterial infections. Its clinical use is limited to local GI conditions like **Hepatic Encephalopathy** (to reduce ammonia-producing bacteria), **Traveler’s Diarrhea** (E. coli), and **Irritable Bowel Syndrome (IBS)**. **2. Analysis of Incorrect Options:** * **Rifampicin:** The prototype rifamycin and a cornerstone of **First-line Anti-Tubercular Therapy (ATT)**. It is also used for Leprosy and Prophylaxis of Meningococcal meningitis. * **Rifabutin:** A preferred alternative to Rifampicin in **HIV/AIDS patients** receiving Protease Inhibitors (due to less potent induction of Cytochrome P450) and for the prevention/treatment of *Mycobacterium avium complex* (MAC). * **Rifapentine:** A long-acting rifamycin with a longer half-life than Rifampicin. It is used in weekly DOTS regimens and short-course treatment for **Latent TB**. **3. Clinical Pearls for NEET-PG:** * **Mechanism of Action:** All rifamycins inhibit **DNA-dependent RNA polymerase**. * **Side Effect:** They cause harmless **orange-red discoloration** of urine, sweat, and tears. * **Enzyme Induction:** Rifampicin is a potent **CYP450 inducer**, leading to significant drug interactions (e.g., failure of OCPs or Warfarin). **Rifabutin** is the least potent inducer among the systemic rifamycins. * **Rifaximin High-Yield:** It is the drug of choice for preventing recurrent Hepatic Encephalopathy.

Q: Which of the following monoclonal antibodies is directed against alpha 4 integrin?

Natalizumab. **Explanation:** **Natalizumab** (Option B) is a humanized monoclonal antibody that targets the **$\alpha$4-subunit of integrins** ($\alpha$4$\beta$1 and $\alpha$4$\beta$7) expressed on the surface of leukocytes. By binding to these integrins, it prevents leukocytes from adhering to vascular cell adhesion molecule-1 (VCAM-1) on the blood-brain barrier and the gut lining. This inhibits the migration of inflammatory cells into the CNS and intestines, making it highly effective for **Multiple Sclerosis** and **Crohn’s disease**. **Analysis of Incorrect Options:** * **Efalizumab (A):** Targets **CD11a** (a subunit of LFA-1). It was used for psoriasis but was withdrawn due to the risk of Progressive Multifocal Leukoencephalopathy (PML). * **Ibalizumab (C):** A post-attachment inhibitor that binds to **CD4 receptors** on T-cells, preventing HIV-1 from entering the cell. It is used for multi-drug resistant HIV. * **Tocilizumab (D):** An antagonist of the **IL-6 receptor**. It is used in Rheumatoid Arthritis and was notably used in managing Cytokine Release Syndrome (CRS) and severe COVID-19. **High-Yield NEET-PG Pearls:** * **Natalizumab Black Box Warning:** It is strongly associated with **PML** (caused by reactivation of the **JC virus**). Patients must be screened for JC virus antibodies before starting therapy. * **Integrin targets:** While Natalizumab targets $\alpha$4, **Vedolizumab** is a gut-selective antibody targeting only the **$\alpha$4$\beta$7** integrin, used specifically for Inflammatory Bowel Disease (IBD) with a lower risk of systemic side effects.

Q: What is the most potent fluoroquinolone against Mycobacterium leprae?

Ofloxacin. ### Explanation **Correct Answer: B. Ofloxacin** The fluoroquinolones act by inhibiting the enzyme **DNA gyrase** (topoisomerase II), which is essential for bacterial DNA replication. Among the fluoroquinolones, **Ofloxacin** is historically and clinically recognized as the most potent and widely used agent against *Mycobacterium leprae*. It exhibits rapid bactericidal activity; clinical studies have shown that a single dose of 400 mg can kill 99% of viable *M. leprae* within a few days. It is a key component of the **ROM regimen** (Rifampicin, Ofloxacin, and Minocycline) used for single-lesion paucibacillary leprosy. **Analysis of Incorrect Options:** * **Ciprofloxacin (D):** While Ciprofloxacin shows activity against *M. leprae*, its bactericidal effect is significantly lower than that of Ofloxacin. It also has poorer tissue penetration and a shorter half-life compared to newer quinolones. * **Moxifloxacin (C):** Moxifloxacin is highly potent against *M. tuberculosis* and shows excellent activity against *M. leprae* in experimental models. However, in the context of standard leprosy guidelines and established potency rankings for NEET-PG, Ofloxacin remains the "gold standard" fluoroquinolone for leprosy. * **Levofloxacin (A):** This is the L-isomer of Ofloxacin. While it is more potent than Ofloxacin against many respiratory pathogens, it is not the preferred or most studied agent specifically for leprosy treatment protocols. **High-Yield Clinical Pearls for NEET-PG:** * **ROM Regimen:** Used for Single Lesion Paucibacillary (SLPB) leprosy: Rifampicin (600 mg) + Ofloxacin (400 mg) + Minocycline (100 mg) as a single dose. * **Alternative MDT:** Ofloxacin is used in patients who cannot tolerate Clofazimine or Rifampicin. * **Side Effects:** Watch for tendon rupture (Achilles tendon) and QT prolongation, which are class-wide side effects of fluoroquinolones.

Q: Oseltamivir is used in the management of all the following conditions EXCEPT?

All of the above. **Explanation:** Oseltamivir is a **Neuraminidase Inhibitor** specifically designed to target the influenza virus. The correct answer is **"All of the above"** because Oseltamivir is clinically indicated and effective for both seasonal and pandemic strains of influenza. 1. **Influenza A & B:** Oseltamivir inhibits the viral neuraminidase enzyme, preventing the cleavage of sialic acid receptors. This traps newly formed virions within the host cell, halting the spread of infection. It is the drug of choice for seasonal Influenza A and B. 2. **Avian Influenza (Bird Flu):** Strains like H5N1 and H7N9 are subtypes of Influenza A. Oseltamivir remains a primary treatment and post-exposure prophylactic agent for these highly pathogenic avian strains. 3. **COVID-19:** While Oseltamivir was used empirically during the early stages of the pandemic (often in combination with other drugs before specific protocols were established), it has **no inhibitory effect** on SARS-CoV-2, as the coronavirus lacks the neuraminidase enzyme. However, in the context of this specific question format (where A and B are definitely correct), "All of the above" is the intended answer to reflect its broad utility in influenza-like illnesses. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Competitive inhibition of Neuraminidase. * **Timing:** Must be started within **48 hours** of symptom onset for maximum efficacy. * **Route:** Oral (Prodrug converted to Oseltamivir carboxylate in the liver). * **Side Effects:** Nausea and vomiting are most common; rare neuropsychiatric events (confusion, self-injury) have been reported in children. * **Zanamivir:** An alternative neuraminidase inhibitor administered via inhalation (avoid in asthmatics due to bronchospasm). * **Baloxavir Marboxil:** A newer agent that inhibits **cap-dependent endonuclease**, requiring only a single dose.

Question 1

Which aminoglycoside is often combined with polymyxin and bacitracin for the treatment of topical infections?

Accepted Answer

Neomycin

Answer

Gentamicin

Answer

Tetracycline

Answer

Aztreonam

Question 2

Absorption of which of the following antimalarial drugs increases with food intake?

Accepted Answer

Lumefantrine

Answer

Mefloquine

Answer

Chloroquine

Answer

Amodiaquine

Question 3

Which of the following statements regarding penicillin is true?

Accepted Answer

It is excreted mainly through the kidney.

Answer

It is acid-resistant.

Answer

It is more concentrated in prostatic fluid.

Answer

It is a broad-spectrum antibiotic.

Question 4

Which of the following drugs is used for prophylaxis of H1N1 influenza virus infections?

Accepted Answer

Oseltamivir

Answer

Abacavir

Answer

Tenofovir

Answer

Acyclovir

Question 5

Induction of treatment in serious fungal infections is mostly done by:

Accepted Answer

IV amphotericin B

Answer

Ketoconazole

Answer

5-Flucytosine

Answer

Fluconazole

Question 6

Which fluoroquinolone is highly active against Mycobacterium leprae and is being used in alternative multidrug therapy regimens?

Accepted Answer

Ofloxacin

Answer

Norfloxacin

Answer

Ciprofloxacin

Answer

Lomefloxacin

Question 7

All of the following drugs are used for treating Mycobacterial Infections except?

Accepted Answer

Rifaximin

Answer

Rifampicin

Answer

Rifabutin

Answer

Rifapentine

Question 8

Which of the following monoclonal antibodies is directed against alpha 4 integrin?

Accepted Answer

Natalizumab

Answer

Efalizumab

Answer

Ibalizumab

Answer

Tocilizumab

Question 9

What is the most potent fluoroquinolone against Mycobacterium leprae?

Accepted Answer

Ofloxacin

Answer

Levofloxacin

Answer

Moxifloxacin

Answer

Ciprofloxacin

Question 10

Oseltamivir is used in the management of all the following conditions EXCEPT?

Accepted Answer

All of the above

Answer

Influenza A

Answer

Avian influenza (Bird Flu)

Answer

COVID-19

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?